Xi'an Plasma, formerly known as Xi'an Huitian Blood Products Co., Ltd, was established in October 1996 as one of the first national designated blood product manufacturing enterprise and also the first biopharmaceutical enterprise  to pass GMP certification in Shaanxi Province. Its annual plasma fractionation capacity reaches 400 tons. Its human albumin and intravenous immunoglobulin products have been listed as recommended products for the European Union market by the French Technical Quality Supervision and Evaluation Committee, and also boast high popularity and market influence in the northwest of China, Shandong provinces, Henan province and other regions.

In August 2022, BTBP completed the acquisition of Xi'an Huitian and renamed it as "Sinopharm Xi'an Biopharmaceuticals Co., Ltd".